Garrison Michael David 4
4 · BECTON DICKINSON & CO · Filed Nov 29, 2024
Insider Transaction Report
Form 4
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Transactions
- Award
Common Stock
2024-11-26+2,553→ 7,934 total - Award
Stock Appreciation Rights
2024-11-26+10,004→ 10,004 totalExercise: $224.25From: 2025-11-26Exp: 2034-11-26→ Common Stock (10,004 underlying) - Tax Payment
Common Stock
2024-11-26−1,230→ 8,979 total - Award
Common Stock
2024-11-26+2,275→ 10,209 total
Footnotes (4)
- [F1]Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
- [F2]Represents shares received upon vesting of performance based equity award.
- [F3]Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.
- [F4]The stock appreciation rights vest in four annual installments beginning November 26, 2025.